← Back to companies
Merida Biosciences
0 open
Cambridge, Massachusetts, United StatesFounded 202250+ employeesSeries A raisedSeries APrivate
Last round: series a · $121M · Apr 2025(2 rounds total)
Backed by(5 investors)
Third Rock VenturesBain Capital Life SciencesBiotechnology Value FundPerceptive AdvisorsGoogle Ventures
Merida Biosciences is a biotechnology company pioneering a new class of precision therapeutics designed to selectively and durably eliminate pathogenic antibodies that drive disease. The company is advancing a robust pipeline to precisely eliminate the root cause of multiple autoimmune and allergic conditions that are inadequately treated today. Its lead program is designed to specifically and rapidly clear the pathogenic autoantibodies that cause Graves' disease, an autoimmune disorder that affects the thyroid gland. Merida was publicly launched in April 2025 and is based in Cambridge, MA. For more information about Merida, visit www.meridabio.com.
Open Positions at Merida Biosciences (0 Jobs)
No open positions at the moment.
Browse All JobsReady to start your space career at Merida Biosciences?
